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Abstract  
      This article provides an overview of the U.S. health care reform debate and legislation, with a focus 
on health insurance.  Following a synopsis of the main problems that confront U.S. health care and 
insurance, it outlines the health care reform bills in the U.S. House and Senate, including the key 
provisions for expanding and regulating health insurance, and projections of the proposals’ costs, 
funding, and impact on the number of people with insurance. The article then discusses (1) the potential 
effects of the mandate that individuals have health insurance in conjunction with proposed premium 
subsidies and health insurance underwriting and rating restrictions, (2) the proposed creation of a public 
health insurance plan and/or non-profit cooperatives, and (3) provisions that would modify permissible 
grounds for health policy rescission and repeal the limited antitrust exemption for health and medical 
liability insurance.  It concludes by contrasting the reform bills with market-oriented proposals and with 
brief perspective on future developments.   
 
 
 
 
 
 
*Alan B. Miller Professor of Health Care Management and Insurance and Risk Management, Wharton 
School, University of Pennsylvania and an adjunct scholar at AEI (http://scottharringtonphd.com).  I 
thank Tom Miller of AEI for many helpful comments and input and Emi Terasawa for research 
assistance.
1 
 
INTRODUCTION 
 At least three broad problems characterize U.S. health care and insurance:  (1) high and rapidly 
growing costs, (2) large numbers of non-elderly people without insurance, and (3) enormous projected 
Medicare deficits and continued Medicaid cost growth.  The health care reform debate and reform 
proposals have focused largely on expanding the number of people with health insurance.  On November 
7, 2009, the U.S. House of Representatives narrowly approved legislation to mandate that all individuals 
be covered by health insurance coupled with Medicaid expansion, premium subsidies for low income 
persons, creation of a health insurance exchange (or exchanges) with strong restrictions on health 
insurance underwriting and pricing, and creation of a government-run health insurer to compete with 
private health plans.  While the details differ, on November 21 the U.S. Senate voted 60-39 along straight 
party lines to approve for floor debate a bill with the same broad outlines.   
 Passage of health care legislation with these features would transform U.S. health insurance.  
Massachusetts is the only state with an individual health insurance mandate, enacted in 2006.1  Relatively 
few states have strict restrictions on health insurance underwriting and pricing of the type proposed in the 
Congress.2  Debate over the majority Democrats’ proposals for expanding health insurance has been 
highly partisan.  Democrats stress the importance of expanding coverage.  Liberal and progressive 
members strongly favor a public insurer to compete with private insurers.  Some favor a public plan as a 
significant step towards the ultimate goal of universal coverage under a single payer system.  
Congressional Republicans are nearly unanimous in their opposition to the Democrats’ reform agenda, 
especially the creation of a public plan.  They propose narrowly target reforms and market-oriented 
changes in health insurance markets and taxation to expand coverage while helping to control costs.3  
 This paper provides an overview of the U.S. health care debate and reform bills in the U.S. House 
and Senate, with a focus on proposals that deal directly with health insurance.  The House and Senate bills 
would significantly expand health insurance coverage beginning in 2013 (the House bill) or 2014 (the 
Senate bill) through a mandate for individuals to have health insurance, Medicaid expansion, and 
premium subsidies to persons with incomes up to 400 percent of the federal poverty level for coverage 
purchased through a new health insurance exchange (or exchanges).  The projected costs of 
approximately $1,050 billion for the House bill and $850 billion for the Senate bill through 2019 would 
be financed largely through new taxes and Medicare spending cuts that would begin in 2010.    
 The paper elaborates the bills’ coverage and funding provisions and evaluates the potential effects 
of the proposed health insurance reforms.  The paper’s main points concerning the effects of the proposed 
reforms are summarized below: 
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 An individual mandate would reduce the total cost of explicit subsidies needed to achieve any 
given increase in the percentage of people with insurance, including the costs that arise from 
crowding out unsubsidized coverage.  The greater the penalties for non-compliance, the lower 
would be the total cost.  A “weak mandate” would require larger explicit subsidies and/or result 
in fewer people being insured than a “strong mandate.”  
 The proposed guaranteed issue of coverage without preexisting condition exclusions, prohibition 
of premiums based on health status, and limits on age-related premium variation would provide 
implicit (off budget) premium subsidies to older and/or less healthy purchasers of individual and 
small group health insurance, which would be financed with implicit (off budget) taxes in the 
form of higher premium rates for younger and/or healthier buyers.  Those restrictions would 
produce some degree of adverse selection as some younger and healthier people would delay 
buying coverage until they needed expensive care, increasing the average cost of coverage. The 
effects could be large without a strong coverage mandate.  The Senate bill’s relatively weak 
penalties in particular would risk significant adverse selection. 
 An individual mandate would put upward pressure on total health care expenditures and 
premiums apart from any adverse selection.  Utilization of health care on average would increase 
for people who obtained coverage in response to the reforms.  In addition, a mandate necessarily 
requires government prescription of the types and amounts of medical services that must be 
insured.   The proposed minimum permissible coverage packages include broader benefits and 
less cost sharing than some people currently obtain voluntarily.  Increased coverage would lead to 
some increase in moral hazard and excessive utilization of medical care.  Costs also would likely 
increase due to higher prices for medical services until the supply of health care providers 
expanded to meet increased demand for care.   
 An individual mandate would affect decisions about the specific services that would be 
reimbursed by insurance.  A mandate and proposed insurance market reforms would likely be 
accompanied, if not initially then ultimately, by coverage determinations by the Department of 
Health and Human Services or other federal agency.  The ultimate reach of federal authority 
would depend on whether it was extended to large employer plans and/or the reforms eventually 
produced significant depopulation of such plans.   
 Proponents argue that a public health insurance plan would lower premiums by reducing 
administrative costs, eliminating profits, and lowering reimbursement to providers.  The main 
source of potential savings would be lower reimbursement.  Health insurers’ profit margins 
typically average about three percent (less for non-profit insurers); and administrative expense 
ratios average about 11-12 percent.  Medicare’s much lower administrative expense ratio 
primarily reflects higher average medical claim costs; the exclusion of general overhead, 
enrollment, and billing costs; and that Medicare does not negotiate with providers, engage in 
medical management, spend much to reduce fraud, or incur state premium taxes or regulatory 
compliance costs that affect private insurers.   
 If a public plan were to base reimbursement on Medicare rates, with or without a modest markup, 
the plan would shift costs to and increase potential crowd-out of private health plans, and it would 
threaten the financial stability of some hospitals and physicians.  The House and Senate bills’ 
proposal to have the public plan negotiate rates with voluntary provider participation would 
reduce those risks, but pressure for cost control could cause reimbursement and participation rules 
to tighten over time.   
 Even with negotiated rates and other suggested safeguards, equal competition between private 
insurers and a public plan is infeasible.  A public plan would hold less capital than private 
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insurers and ultimately be backed by taxpayers.  It would not pay the taxes that private insurers 
pay.  For these reasons alone, a public plan could have a cost advantage of five percent or more.   
 Proposed subsidies for the creation of government-authorized, non-profit health insurance 
cooperatives would likewise create some risk of on-going subsidies by taxpayers and crowd-out 
of other plans.  The economic rationale for such co-ops is very thin.   
 The bills would override many states’ laws regarding health insurance policy rescissions, which 
generally permit rescission only on the basis of incorrect or concealed information that would 
have changed the insurer’s decision to offer coverage or the premium charged.  The bills would 
require insurers to prove fraud (intent).  The practical effect might be minimal given the bills’ 
underwriting and rating restrictions.  Otherwise, requiring proof of intent would be expected to 
increase underwriting costs, claim costs, and premiums.   
 The House bill would repeal the limited antitrust exemption for health insurance and medical 
liability insurance.  An amendment to that effect will likely be proposed in the Senate.  The 
antitrust exemption has not contributed to higher health insurance premiums, profits, or market 
concentration.  Unlike many property/casualty insurers, health insurers do not engage in 
cooperative activity to project claim costs. The exemption does not prevent review and challenge 
of mergers by the Department of Justice or state insurance regulators.  Repeal would not 
significantly increase health insurance competition or make coverage less expensive.  Unintended 
consequences of repealing the exemption for medical liability insurance could include increased 
ratemaking costs, reduced rate accuracy, and less competition. 
 The long-run effects of the House and Senate bills would depend to a significant extent on 
whether employer-sponsored coverage remained dominant, at least for large employee groups, 
with plan design and benefit determination governed largely by competition and private 
contracting.  Under one scenario, a significant majority of the non-elderly population would 
continue for many years to receive coverage on that basis.  An alternative scenario would see the 
extension of government authority over plan design, financing, and reimbursable care throughout 
the market, and/or a steady reduction in employer-sponsored coverage and concomitant increase 
in coverage obtained through heavily regulated exchanges or a public plan. 
 The next section briefly elaborates the main problems that confront U.S. health care and insurance:  
high and rising costs, a large uninsured population, and large projected deficits for Medicare.  The paper 
then turns to the House and Senate bills, outlining the key provisions for expanding and regulating health 
insurance and Congressional Budget Office (CBO) projections of the proposals’ costs, funding, and 
impact on the number of people with health insurance.  The next section considers the potential effects of 
the mandate that individuals have health insurance, premium subsidies, and proposed insurance market 
reforms.  The proposed creation of a public health insurance plan and/or non-profit cooperatives and 
provisions that would modify permissible grounds for health insurers to rescind coverage and repeal the 
limited antitrust exemption for health and medical liability insurance are then considered.  The paper 
concludes by contrasting the reform bills with market-oriented reforms and with brief perspective on 
future developments.   
  
4 
 
MOTIVATION FOR REFORM 
Costs and Cost Growth 
 Figure 1 shows U.S. health expenditures as a percentage of Gross Domestic Product (GDP) and 
annual growth rates in per capita health spending during 1962-2007.  The percentage of GDP devoted to 
health care grew from under six percent to over 16 percent during that time.  Real annual growth in per 
capita expenditures averaged 4.3 percent.  Real per capita spending grew 6.2 percent annually during the 
1960s, which included the creation of Medicare and Medicaid in 1965, and then 3.6 percent and 3.9 
percent annually during the 1970s and 1980s, respectively.  Real per capita spending growth slowed to 
2.6 percent in the 1990s and has increased at 3.3 percent annually this decade. 
 Figure 2 shows per capita health expenditures in 2007 for OECD countries with available data, 
adjusted for U.S. purchasing power parity.  The U.S. expenditure of $7,290 was 53 percent larger than 
that of the second highest country.  Figure 3 plots compound annual growth rates in per capita health 
expenditures for OECD countries during 1997-2006 versus the countries’ per capita expenditure in 1997.4  
While the 6 percent (nominal) U.S. compound growth rate in per capita expenditures ranked 15th out of 25 
countries, the U.S. growth rate is a clear outlier compared with trend.    
 Explanations of why the U.S. spends much more than other countries generally point to greater 
rates of technology adoption and diffusion and higher compensation for health care providers, along with 
the lesser role played by government in financing medical care.5  The consensus is that the U.S. system of 
government and private insurance has significantly increased expenditures and expenditure growth.6  
Despite the large numbers of uninsured, the U.S. ranks well above average among OECD countries in the 
proportion of national health expenditures reimbursed by insurance (see Figure 4).  It ranks first by a large 
margin in the proportion of spending reimbursed by private insurance. 
 The high average health expenditure in the U.S. is associated with high average health insurance 
premiums.  The Kaiser/HRET survey of employer-sponsored health benefits reports an average premium 
(employer and employee combined) for family coverage in 2009 of $13,375, 131 percent greater than for 
1999, with an average worker contribution of $3,515 (Kaiser/HRET, 2009).  The average premium for 
single coverage in 2009 was $4,824, with the worker contributing an average of $779.  Given greater 
average cost-sharing and less generous benefits chosen, average individual health insurance market 
premiums in 2009 were much lower, despite higher expense loadings.  According to an AHIP survey of 
2.5 million policies, the average premium for single coverage in the individual market was $2,985, and 
the average premium for family coverage was $6,328 (AHIP, 2009).  The average annual premium for 
individual (family) coverage ranged from $1,429 ($2,967) for 18-24 year olds to $5,715 ($9,952) for 60-
64 year olds (see Figure 5). 
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 The question of whether the higher cost of U.S. medical care produces significantly higher quality 
is much debated.  U.S. infant mortality rates are high among developed countries.  Americans do not have 
higher average life expectancies.  The U.S. ranks highly on survival rates for certain cancers and 
generally is characterized by greater innovation and more rapid diffusion of medical technology, new 
drugs, and biologics.  Waiting times for non-critical surgeries are significantly lower in the U.S. than in 
many other countries.  Americans generally are more likely to be obese, but less likely to smoke than 
residents of many other developed countries.  Health care expenditures and quality of care vary widely 
within the U.S.  A sizable literature, for example, documents large regional variations in Medicare 
spending and considers whether that variation is related to quality, as well as whether Medicare 
expenditures could be cut in high cost regions without significantly reducing quality (see, for example, 
Skinner, et al., 2009; Cooper, 2009).    
The Uninsured 
 The high costs of health care and insurance influence many people to forego coverage.7  High 
premiums and the large number of uninsured have contributed to allegations that private insurance 
markets are substantially dysfunctional (see below).  The most widely cited estimates of the uninsured 
population are based on the Current Population Survey (CPS).  It is estimated from that source that 
approximately 46 million U.S. residents did not have health insurance in 2008, representing 17.4 percent 
of the non-elderly population.8  Compared with the insured non-elderly, the uninsured on average have 
significantly lower income and educational attainment, are less likely to be employed full time, are more 
likely to be black and/or of Hispanic origin, are more likely to be young adults than middle aged, and are 
less likely to report being in excellent or very good health.9  Roughly a quarter of the uninsured were 
eligible for Medicaid, but had not enrolled (Kaiser Family Foundation, 2009; also see NIHCM, 2008).  
Roughly 10 million lived in households where a member declined employer-sponsored coverage.   
 An estimated 38 million (20.4 percent) of the adult non-elderly population were uninsured.  About 
8 million were non-U.S. citizens.  Estimates suggest that at least half of those persons are unauthorized 
immigrants (see NIHCM, 2008).  Approximately 4 million had income above 400 percent of the federal 
poverty level in 2008 (Kaiser Family Foundation, 2009, Supplementary Data Tables, p. 3).10  The 
duration of time spent without insurance varies widely.  The proportion of non-elderly uninsured has 
remained relatively steady since 1990, with a decrease in private insurance offset by an increase in public 
coverage (Cohen, et al., 2009). 
 Uninsured rates vary widely across U.S. states in relation to income, age, race, ethnicity, and other 
socio-economic and demographic factors.  Figure 6 illustrates cross-state variation in uninsured rates 
during 2007-2008 (obtained from Kaiser Family Foundation, 2009) for the continental U.S.  It shows the 
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average percentage of the adult non-elderly population without health insurance for quartiles of states 
ranked by the percentage uninsured, along with the within quartile averages of the percentage of the 
population with income below federal poverty level (FPL), the percentage of the state’s population that 
was African-American (black), and the percentage of the population of Hispanic origin (Hispanic).  States 
with the highest uninsured rates had considerably greater poverty and proportions of black and Hispanic 
residents than states with the lowest uninsured rates.  Median household income is considerably lower in 
the states with high uninsured rates (not shown).        
 Again using data for the lower 48 states, Table 1 shows descriptive linear regressions (with no 
pretense of causal inference) of the percentages of the adult non-elderly population in 2007-2008 with 
employer-sponsored health insurance and no insurance as functions of state median household income, 
the proportion of the adult non-elderly population with public coverage (Medicaid and Medicare or 
military), and the proportion of the total population that is black or Hispanic.11  The employer coverage 
rate is strongly and positively related to median household income, and it is strongly and negatively 
related to the proportion of non-elderly adults with public coverage, and, especially, the proportion of the 
state’s total population that is Hispanic.  The uninsured rate is strongly and negatively related to median 
household income and public coverage, and it is positively related to the proportion black and the 
proportion Hispanic.   
 Estimates suggest that the uninsured paid about a third of the cost of their medical care and 
produced an estimated at $56 billion in uncompensated care for providers in 2008, with government 
funding covering about 75 percent of the cost of uncompensated care and approximately $14 billion 
potentially being shifted to private health insurance (Hadley, et al., 2008).12  While causal inference is 
challenging given unobserved heterogeneity and related issues, the consensus is that lack of insurance 
negatively affects access to health care and health.13  The uninsured are entitled to hospital 
emergency/acute care to stabilize their conditions without regard to ability to pay, and many uninsured 
with low incomes obtain care from community health centers.  But being uninsured on average is 
associated with a lower likelihood of having a usual source of medical care, less use of preventive 
medical care, greater likelihood of foregoing medical care due to cost, and, while the magnitude of the 
increase is debated, a greater likelihood of bankruptcy due to unpaid medical bills. 
 While the number of people that are uninsured in relation to preexisting conditions and loss of 
insurance after job loss and exhaustion of continuation of coverage benefits is not known, these sources of 
uninsurance and difficulty in affording health insurance are widely regarded as problematic.  Figure 5 also 
shows individual health insurance denial rates by age group from AHIP (2009) survey data.  The overall 
denial rate was 12.7 percent.  The extent to which applicants denied coverage were able to obtain 
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coverage from another insurer or source is not known.  The AHIP survey also reports that 34 percent of 
offers were at higher than standard premium rates (36 percent of offers were below standard rates) and 
that six percent of offers included a waiver of coverage for one or more health conditions.  While health 
insurance policy rescissions are unlikely to represent a significant source of uninsurance, health insurers’ 
rescission practices have received scrutiny (see below).  The possibility of being denied coverage, or 
having to pay a higher premium if disclosure is truthful, likely leads to more applications with 
misrepresentations or concealments and to higher rescission frequencies.           
The Medicare / Healthcare Spending Deficit 
 Large projected Medicare deficits and continued Medicaid cost growth represent a third major 
problem confronting U.S. health care.14  The funding of Medicare in particular poses major challenges in 
from real cost increases per enrollee and aging of the population.  The Medicare Trustees (2009) 
estimated the present value of the projected Medicare deficit over the next 75 years at $38 trillion as of 
year-end 2008 (using their intermediate economic assumptions about real interest rates, general inflation, 
Medicare spending growth, GDP growth, and population growth).  That figure is equivalent to about 2.6 
times 2008 U.S. GDP, or about $250,000 per adult aged 16-64.15  While much of projected deficit reflects 
forecasts beyond 2020, the hospital insurance trust fund is projected to exhaust in 2017 under the status 
quo. 
Of the $38 trillion projected present-value deficit, $13.4 trillion is for projected shortfalls in 
payroll taxes versus expenditures for the Medicare hospital insurance program (Part A).  The remaining 
$24.4 trillion is for projected future general revenue transfers to pay the federal government’s share 
(about 75%) of projected Medicare spending for outpatient services and prescription drugs (Parts B and 
D).  The federal government transferred $184 billion of general revenues to pay its share of Medicare 
spending for outpatient services ($147 billion) and prescription drugs ($37 billion) in 2008.  That $184 
billion and future increases commensurate with GDP growth might be viewed as already built into the 
federal budget, so that the $37.8 trillion figure overstates the unfunded deficit.  If the $184 billion were to 
grow at the Trustees’ projected growth rates for GDP, the present value of the required general revenue 
transfers for outpatient services and prescription drugs would be $13.5 trillion less than the $24.4 trillion 
included in the $37.8 trillion figure.  The combined deficit for excess of GDP outpatient service and 
prescription drug spending growth and the hospital insurance program is $27 trillion, about 1.9 times 
2008 GDP, or roughly $175,000 per adult aged 16-64.16  The unsustainability of Medicare spending has 
significantly influenced the debate over how to finance expanded health insurance for the non-elderly. 
  
8 
 
HOUSE AND SENATE REFORM PROPOSALS 
 The U.S. House of Representatives approved the Affordable Health Care Act on November 7, 
2009 by a vote of 220-215 with one Republican voting in favor.  On November 21, the Senate voted 60-
39 with no Republican support to approve the Patient Protection and Affordable Care Act for floor 
debate.  The bill reflects a number of changes to the one approved by the Senate Finance Committee in 
October, including a proposed public option.  If the full Senate approves the bill, with or without 
amendments, the House and Senate conferees will negotiate final terms for a vote by both chambers.   
Table 2 summarizes the major features of both bills, which are similar in many key respects.  A 
number of the bill’s main features are consistent with President Obama’s campaign platform for health 
care reform.   Notable differences include the proposed mandate for adults to be insured and the proposed 
public insurance plan.  Both bills would establish a pool for offering coverage to buyers with preexisting 
conditions at subsidized premium rates as a transition mechanism until creation of the health insurance 
exchange (or exchanges) with premium subsidies and implementation of market-wide underwriting and 
rating restrictions. 
Coverage Expansion 
 Both bills would require most legal residents to have health insurance that meets minimum 
requirements specified by the government, beginning in 2013 in the House bill and 2014 in the Senate 
bill.  Eligibility for the taxpayer funded Medicaid program would be expanded to all persons with income 
below 150 percent of FPL in the House bill and 133 percent of FPL in the Senate bill.  Substantial 
premium subsidies would be provided to non-Medicaid eligible buyers with incomes up to 400 percent of 
FPL through a sliding threshold of premium caps as a percentage of income, and lower-income 
households would be able to purchase coverage with a higher estimated actuarial value and thus lower 
cost-sharing at the subsidized rates.  Figure 7 illustrates the maximum premiums that a family of four 
would have to pay and the associated actuarial values of coverage.  Apart from small very small 
establishments, the House bill would require employers to offer health coverage and contribute much of 
the cost or pay a tax up to 8 percent of payroll.  The Senate bill would require employers with 50 or more 
workers who fail to offer coverage to pay $750 per worker.  Both bills would provide modest tax credits 
for very small business that provide coverage.  The CBO projects that the House (Senate) bill would 
result by 2019 in coverage of 96 percent (94 percent) of non-elderly legal residents, compared with 
approximately 83 percent today.17   
Insurance Market Reforms   
Both bills would dramatically alter insurance markets and regulation.  The House bill would 
establish a new federal regulatory and oversight agency.  The Senate bill would utilize the Department of 
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Health and Human Services and leave most enforcement to the states.  Subsidy-eligible and other persons 
not covered through employment-based coverage, Medicare, or Medicaid would be able to buy coverage 
through a new health insurance exchange (or, in the Senate bill, state-level exchanges) patterned after 
reforms enacted in Massachusetts in 2006 (discussed further below).18  The government would mandate 
broad coverage of services and levels of cost sharing from which consumers could choose (with 
additional limits on cost sharing for low-income buyers as noted above).  Health insurers would have to 
accept all applicants regardless of health status, without excluding coverage for preexisting conditions.  
Premium rates would be allowed to vary by coverage, geographic region, and, within a restricted range, a 
person’s age.  The House bill would permit a 2-1 age range; the Senate bill would permit a 3-1 range.  
The Senate bill also would allow variation up to 1.5-1 for tobacco use.  Both bills propose ex post risk 
adjustment among insurers to help equalize underwriting experience across insurers.19  
The House bill would repeal the antitrust exemption for the “business of insurance” for health 
insurance and for medical liability insurance, subject to a safe harbor clause governing projected loss 
development and certain other activities.  The final Senate bill could be amended to include a similar 
provision.  The House bill would require all health insurers to achieve a minimum loss ratio of 85 percent 
and to refund premiums if necessary to achieve that minimum, subject to regulatory discretion to relax the 
criterion to avoid undue market disruption.  Both bills would prohibit insurers from rescinding policies 
for material misrepresentations or concealment unless the insurer could prove fraud or intentional 
misrepresentation by the applicant.    
Both bills would create a government-run health insurer – a public plan – to offer insurance 
through the exchange in competition with private insurers.  The bills stipulate that the public plan would 
be self-sustaining and would negotiate reimbursement rates with providers.  The Senate bill would allow 
states to opt out of the public plan provisions.  Both bills also would provide grants and loans for the 
creation of non-profit health insurance cooperatives on a state or regional basis.  The public plan and 
cooperative proposals are discussed further below.  
Funding Coverage Expansion     
 According to CBO 10-year projections, the expansion of coverage is projected to cost $1,052 
billion under the House bill and $848 billion under the Senate bill (Table 2).  The CBO projects 
$781billion in taxes and fees under the House bill, including $460 billion in tax surcharges on high 
income taxpayers and $168 billion in individual and employer penalties for non-compliance.  Projected 
Medicare spending would decline by close to $400 billion under the House bill, including $170 billion in 
reduced reimbursement to Medicare Advantage.  The CBO projects that the Senate bill would generate 
$486 billion in revenues, including $54 billion in new taxes on high-income earners for Medicare Part A, 
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$149 billion in excise taxes on high cost health plans, $60 billion in taxes on health insurers, and $41 
billion in taxes on brand name drug and medical device manufacturers.  Projected Medicare spending 
would fall by $436 billion under the Senate bill, including $118 billion in cuts in Medicare Advantage.  
Overall, the CBO projects that the House and Senate bills would reduce the 10-year federal deficit by 
$109 billion and $130 billion, respectively.   
The CBO’s cost, revenue, and deficit projections depend on numerous assumptions and are 
subject to considerable uncertainty, as well as to pay-as-you-go accounting.  The cost projections would 
be significantly higher if not for the delayed implementation of Medicaid expansion and premium 
subsidies.  The House and Senate bills project $102 billion and $72 billion in deficit reduction, 
respectively, from net receipts from creation of a federal long-term care insurance program, without 
reflecting the new program’s projected accrual of liabilities.  The projections of Medicare savings assume 
that payment rates for many providers would be held below the rate of inflation and that a proposed 
independent advisory board for Medicare would be “fairly effective in reducing costs” (Elmendorf, 2009, 
regarding the Senate bill).  In his November 19 commentary on the Senate bill projections, CBO Director 
Douglas Elmendorf stated that extrapolations beyond 10 years indicate that Medicare spending growth 
will average 6 percent over the next two decades (2 percent real growth per beneficiary), compared with 
annual growth of 8 percent the past two decades (4 percent real growth per beneficiary).  He concluded 
(Elmendorf, 2009):  “Whether such a reduction in the growth rate could be achieved through greater 
efficiencies in the delivery of health care or would reduce access to care or diminish the quality of care is 
uncertain.” 
THE INDIVIDUAL MANDATE, SUBSIDIES, AND RATING RESTRICTIONS 
 A centerpiece of the House and Senate bills is the mandate for individuals to have health 
insurance, along with expanded Medicaid eligibility, premium subsidies, creation of an exchange (or 
exchanges), and restrictions on health insurance underwriting and rating.  The basic structure of the 
proposals largely mimics the 2006 Massachusetts reforms, which included an individual mandate, 
Medicaid expansion, premium subsidies for people with incomes up to 300 percent of the FPL, merger of 
the small group and individual markets, and an annual fine of $295 per worker on employers who fail to 
make a “fair and reasonable” contribution towards workers’ health coverage.  The Massachusetts’ reforms 
were followed by an estimated increase in the insured population from 90 percent to 97 percent.  Surveys 
indicate that a significant majority of people are satisfied with the reforms, although half of those 
surveyed who were forced to buy insurance disapproved (Blendon, et al., 2008).  The costs of Medicaid 
expansions and premium subsidies have exceeded projections, in part because take up has exceeded 
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expectations.  A state appointed commission has recommended that the state move towards universal 
managed care with capitation as a means to control costs (Steinbrook, 2009). 
 The welfare effects of an individual mandate with Medicaid expansion, premium subsidies, and 
health insurance underwriting and rating restrictions are extremely complex (CBO, 2008).20  An 
individual mandate might have informational and behavioral effects on purchase decisions of the 
uninsured apart from financial incentives provided by subsidies and penalties.  Expanding health 
insurance coverage with a mandate, Medicaid expansion, premium subsidies, and underwriting and rating 
restrictions involves explicit Medicaid costs and premium subsidies and implicit (off budget) premium 
subsidies to buyers who are able to obtain insurance at below-market rates due to underwriting and rating 
restrictions.  The approach also involves implicit (off budget) taxes in the form of above-market premium 
rates for some buyers.21  The net benefits of the proposals would depend among other factors on the 
magnitude of consumption externalities (the value placed by people on knowing that others have 
coverage); on the amounts, types, and costs of increased utilization of medical care; and on labor market 
effects.  Reductions in uncompensated care would reduce the net cost of subsidies.  
Explicit premium subsidies and a mandate with sanctions for non-compliance will increase 
demand for coverage.  Underwriting and rating restrictions will lower the supply price for older and/or 
less healthy buyers, while increasing the price for younger and/or healthier buyers.  By increasing 
demand, a mandate reduces the total cost of explicit subsidies needed to achieve any given increase in the 
percentage of people with insurance, including the costs that arise from crowding out unsubsidized 
coverage due to imperfect targeting of subsidies.  A mandate also increases the size of the implicit tax 
base to fund below-cost premiums for older and/or less healthy buyers.  The greater the penalties for non-
compliance, the lower will be the explicit cost of required subsidies.  A “weak mandate” will require 
larger subsidies and/or result in fewer people being insured than a “strong mandate.”   
 The effects of health insurance underwriting and rating restrictions on decisions to insure and 
average premium rates also will depend on the strength of the individual mandate and the magnitude of 
explicit premium subsidies.  Guaranteed issue of coverage without preexisting condition exclusions, 
prohibition of premiums based on health status, and limits on age-related premium variation will generate 
some degree of adverse selection as some younger and healthier people face higher premiums and delay 
buying coverage until they need expensive care, increasing the average cost of coverage that is purchased.  
The effects could be large without either generous subsidies or a strong coverage mandate with sizable 
penalties for failure to comply.     
 The Senate bill includes relatively weak penalties for an adult’s failure to buy coverage compared 
to the House proposal (and Massachusetts law).  The fine would start at $95 in 2014, increase to $350 in 
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2015, $750 in 2016, and be indexed to the consumer price index thereafter.  People who faced premiums 
for minimum coverage that exceeded 8 percent of their income would be exempt.  The approval of 
similarly low penalties by the Senate Finance Committee in early October generated substantial pushback 
by private health insurers, who had previously agreed to support proposed insurance underwriting and 
rating restrictions provided they were coupled with a strong mandate.  PricewaterhouseCoopers (PWC, 
2009) released a report, sponsored by AHIP, estimating that the Senate Finance Committee bill’s weak 
mandate, in conjunction with its underwriting and rating restrictions, could increase average premiums for 
individual coverage by 47% by 2016 compared with current law, including the effects of proposed new 
taxes on several health care sectors and possible increased cost shifting from Medicare to private plans.  
Gruber (2009) responded that the PWC study did not consider proposed premium subsidies and ignored 
CBO projections that the Senate Finance Committee bill would result in lower premiums for comparable 
coverage than under current law.  In a subsequent study sponsored by the Blue Cross Blue Shield 
Association, Oliver Wyman (2009) projected that proposed insurance reforms coupled with a weak 
mandate would produce a 50% increase in average medical costs per insured five years after reforms took 
effect compared with current law.  While the assumptions underlying the PWC and Oliver Wyman 
projections are not transparent and debatable, the CBO’s cost projections, also based on opaque 
assumptions, do not consider the potential for adverse selection.22   
 Apart from possible adverse selection issue, and without regard to policies that could reduce health 
care cost growth, an individual mandate with premium subsidies would be expected to put upward 
pressure on total health care expenditures.  Utilization of health care on average will increase for people 
who obtain coverage in response to the reforms.  In addition, a mandate necessarily requires government 
prescription of the types and amounts of medical services that must be insured.23 The proposed minimum 
permissible coverage packages include broader benefits and less cost sharing than some people currently 
obtain voluntarily.  Various provider groups will press for inclusion of their services.  In principle, 
significant minimum benefits are needed to achieve the basic goal of expanding coverage. They also may 
be needed to reduce the ability of lower risk people who face higher than market rates from underwriting 
and rating restrictions from sorting into low-coverage groups to mitigate implicit taxes.  Increased 
coverage will lead to some increase in moral hazard and “excessive” utilization, a widely acknowledged 
contributor to high health care costs.  Costs also could increase due to higher prices for medical services t 
until the supply of health care providers expands to meet increased demand for care.   
 An individual mandate also has implications for the locus and scope of decisions about specific 
types of medical care that will be reimbursed by insurance and thus the amount of such care that will be 
demanded and supplied, including any movement over time towards the adoption of formal cost 
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effectiveness criteria.  Decisions about private insurance coverage currently hinge on medical 
appropriateness and necessity as determined by custom and practice; by contracts between employers, 
employees, and insurers; by preferences of individual insurance buyers; by Medicare national and local 
coverage decisions that influence private insurance coverage criteria; and by numerous state and federal 
laws and regulations.  The proposed individual mandate and insurance market reforms could be 
accompanied, if not initially then ultimately, by coverage determinations by the Department of Health and 
Human Services or other federal agency, perhaps along the lines of coverage determinations for 
Medicare.  The possibility of expanded government control over insurance reimbursement has generated 
significant controversy.  The overall scope of such expansion would depend on whether control 
eventually extended to the employer-sponsored market and/or the reforms eventually produced significant 
reductions in employer-sponsored coverage.   
 The question arises as to the rationale for a federal mandate, subsidies, and insurance market 
reforms given the dearth of activity by the states, especially with respect to mandates.  A common 
explanation is that states generally cannot afford the subsidies needed to make mandates feasible.24  
Gruber (2008, p. 67), for example, concludes that “states cannot meaningfully innovate in this area 
without a massive injection of federal funds.”  This statement begs the questions of why an insufficiency 
of state resources does not indicate that citizens, a significant majority of which are insured, are unwilling 
to pay the costs in higher taxes or reduced health services that mandates would require and how federal 
action could overcome that unwillingness to pay. 
 One argument for why a national health insurance mandate conceivably could be supported by 
voters who reject state-level mandates is that federal reform might help fund premium subsidies by 
substantially reducing Medicare and Medicaid cost growth.  Another possibility is that state mandates are 
deterred by free rider problems that a federal action might avoid.  If a state were to enact the large, 
income-related subsidies needed to support a coverage mandate, it would tend to attract low-income 
people from other states, increasing its total cost of subsidies.  The higher taxes needed from middle and 
upper income taxpayers would likewise encourage some outward migration, including small business 
owners and entrepreneurs, reducing the tax base for financing subsidies.  Although any reduction in 
employment opportunities for low-wage workers would reduce inward migration to obtain subsidized 
insurance, the net result could still be a larger per capita burden on middle- and upper-income residents 
who remained.      
Rate Restrictions and Incentives for Healthy Behavior 
 Unhealthy behavior is a major factor in obesity, diabetes, heart disease, and cancer.  In principle, 
health insurance design can encourage healthy behavior through cost-sharing provisions and pricing (see, 
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for example, Bhattacharya and Sood, 2006, who consider insurance and obesity).  Incentives for healthy 
behavior have traditionally been weak under employer-sponsored coverage, with little or no risk-related 
variation in workers’ contributions to the cost of coverage.  Turnover among employees and policy 
holders also reduces employers’ and insurers’ incentives to make long-term investments to promote 
healthy behavior.  Regarding individual health insurance, basing initial premiums on factors such as 
weight and tobacco use provides some incentive for healthy behavior, but guaranteed renewability of 
individual health insurance at rates that do not reflect individual health and behavior dulls incentives for 
healthy behavior.   
The House and Senate proposals recognize the potential benefits of providing financial incentives 
for healthy behavior in the employer-sponsored market.  Existing regulation permits employers to vary 
employee contributions towards the cost of coverage by up to 20 percent to encourage healthy behavior 
under certain conditions (Mello and Rosenthal, 2008).  Employers have been developing a variety of 
strategies to that end, including linking deductibles or premium contributions to tobacco use, weight 
control, blood pressure, and cholesterol levels.  The bills would increase the permissible variation to 30 
percent and provide regulatory discretion to permit variation up to 50 percent.   
By guaranteeing issue of individual and small group health insurance without preexisting 
condition exclusions at rates that do not reflect health status, the House and Senate bills would make it 
illegal for individual coverage premium rates to reflect health-related behavior (except for smoking in the 
Senate bill).  Benefit design and marketing of coverage also would be regulated in an attempt to keep 
insurers from trying to attract healthier people, and the proposals would authorize risk adjustment 
mechanisms that would reallocate funds from insurers that experience lower medical costs to those with 
higher costs.  If an insurer were to attract relatively more healthy people, or help keep more people 
healthy, it might have to forfeit some of any increase in profits to its competitors.  While it is not clear 
how pricing incentives could be incorporated in the individual or small group markets if sufficient 
flexibility were permitted in an expanded individual health insurance market, the strict rating restrictions 
in the House and Senate proposals would likely deter potential innovation.     
THE PUBLIC PLAN OPTION  
 Both the House and Senate bills include proposals to create a government-run health insurer to 
compete with private plans.  President Obama and Speaker of the House Nancy Pelosi strongly support a 
public plan option as a means to promote competition, choice, and to “keep insurance companies honest.”  
Some analysts argue that a public plan could improve competition and help lower costs by reducing 
profits, administrative expenses, and lowering reimbursement to providers (Hacker, 2008, 2009; Holahan 
and Blumberg, 2008; also see Nichols and Bertko, 2009).  Pauly (2009) explains how a public option 
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could provide choice to people who prefer dealing with government.  Other observers stress that the case 
for a public plan is weak, that level competition would not be feasible, and that a public plan would 
inexorably crowd out private health insurance (e.g., Cannon, 2009; Francis, 2009b).  The Senate Finance 
Committee bill proposed subsidies to create non-profit cooperative health insurers (co-ops) at the state or 
regional level in lieu of a public plan.  The House and Senate bills would subsidize creation of co-ops in 
addition to creating a public plan. 
Competition and Market Structure 
 Private health insurance markets are characterized by high market concentration at the state level 
(Robinson, 2004; American Medical Association, 2007; GAO, 2009).  Concentration is much lower when 
measured at the national level.  The extent and scope of economies of scale or other entry barriers at the 
state level other than some states’ restrictive underwriting, rating, and coverage regulations is not clear.  
Effective entry and competition often depend on the ability to utilize relatively large provider networks 
and achieve sufficient scale to contract effectively with hospitals and physicians.  In most states, insurers 
are able to contract with and utilize the services of large medical service organizations as an alternative or 
supplement to direct contracting. Consolidation in many private health insurance markets has coincided 
with increased consolidation of hospitals and hospital-provider networks, increasing insurers’ ability to 
negotiate favorable rate with providers (and vice versa).   
 Over half of the employer-sponsored health insurance market is self-funded.  Employers 
generally choose among insurers and numerous third party administrators for accessing provider networks 
and claims administration.  Reported insurance market concentration data do not reflect the self-funded 
market served by non-insurance third-party administrators.  Those intermediaries and self-funding in 
general represent a significant source of competition for insurance companies in the employer-sponsored 
market except for small group coverage.  Although often highly concentrated, buyers in the individual 
and small group markets have a choice among numerous insurers and plans in most states (except, for 
example, in New York, with pure community rating), including one or more non-profit insurers.25   
Experience under the Federal Employees Health Benefits Program (FEHBP) indicates that 
effective competition among health insurers without a public plan option.  For decades Federal employees 
and members of Congress have purchased their health insurance through this program, under which 
numerous private insurers compete for employees’ business subject to oversight by the federal Office of 
Personnel Management. The FEHBP is generally acknowledged to work reasonably well, with high levels 
of employee satisfaction (Francis, 2009a).  The provision of Medicare Part D coverage by private plans 
has been successful, with most seniors able to choose among numerous competing plans.  
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Profits and Administrative Expenses 
 Public plan supporters argue that health insurers’ profits and administrative expenses are 
excessive or even unnecessary, driving up the cost of coverage, and that a public plan would achieve 
substantial savings on these dimensions.26  Administrative expenses are viewed as especially high for 
individual and small group coverage.  Table 3 summarizes data on health insurers’ profits, medical loss 
ratios, and administrative expense ratios from a variety of sources and time periods.  Health insurers’ 
profit margins (net income to revenues) typically average about 3 percent (less for non-profits), medical 
loss ratios average roughly 85 percent (higher for non-profits than for-profits), and administrative expense 
ratios average about 11-12 percent.27  The aggregate margin for administrative expenses and profits in 
private plan premiums, including premium equivalents for self-funded plans, has averaged about 12 
percent since the mid 1960s (with little or no trend).  Sherlock (2009) reports an administrative expense 
ratio of 11 percent and 16 percent for the individual and small group markets, respectively, in 2007 using 
data primarily from Blue Cross Blue Shield plans covering 36 million lives.28   
 Insurers’ administrative expenses include for marketing, provider and medical management, 
account and member administration, general overhead, and state premium taxes (which average about two 
percent of premiums) (Sherlock, 2009; American Academy of Actuaries, 2009).  Administrative expense 
ratios and medical loss ratios can vary widely across insurers in relation to (1) their mix of individual, 
small group, ASO, and Medicare/Medicaid related contracts; (2) how they account for ASO contract fees 
and expenses (including whether they are based on premium equivalents for those contracts); and (3) 
insurers’ relative emphases on different types of managed care (Robinson, 1997).   
Private insurers’ administrative expense ratios are commonly compared with those of Medicare, 
which are about 1.5 percent of costs in the fee-for-service program (CBO, 2008).  The low expense ratios 
for Medicare reflect a number of differences from private plans (Sherlock, 2009; American Academy of 
Actuaries, 2009), including: 
1. Per capita claim costs are much higher for Medicare, reducing administrative expenses as a 
proportion of total costs.  
2. Reported Medicare administrative costs usually exclude general overhead for the Center for 
Medicare and Medicaid Services. 
3. Enrollment and billing costs are reflected in Social Security Administration Accounts and not 
attributed to Medicare. 
4. Medicare does not negotiate with providers, engage in medical management, or spend much to 
reduce fraud and abuse. 
5. Medicare does not incur state premium taxes or incur regulatory compliance costs that affect 
insurance companies.  
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Private health plans have strong incentives to spend money to detect and prevent fraud and abuse if 
the expected savings exceeds the expenditure.  The resulting expenditures increase reported 
administrative costs.  A public plan might not have comparable incentives.  It commonly is argued that 
too little money is spent to combat Medicare fraud and abuse, with tens of billions of dollars lost 
annually.   
Provider Reimbursement under a Public Plan 
 A critical issue in the creation of a public plan is how reimbursement rates for health care 
providers would be determined.  Private payers on average reimburse hospitals and physicians at 
significantly higher rates than Medicare (e.g., American Hospital Association, 2009, charts 4.6 and 4.7).  
The House and Senate bills’ approach to having the public plan negotiate rates with providers.  That 
approach is inconsistent with many public plan supporters’ goal of cutting costs by using Medicare 
reimbursement rates or Medicare rates plus a nominal percentage (Hacker, 2008).   However, to the extent 
that Medicare reimbursements already entail significant cost-shifting to private payers, an expansion of 
Medicare payment rates, with or without a modest markup, would further shift costs to and increase 
potential crowd-out of private plans, assuming that providers would accept or be required to accept such 
reimbursement rates.  A strategy of linking public plan reimbursement to Medicare rates could threaten 
the financial stability of hospitals and physician practices that currently operate at low margins.29  
Requiring a public plan to negotiate rates with voluntary participation from providers reduces this risk, 
although the risk remains that pressure for cost control would cause reimbursement and participation rules 
to tighten over time.   
Is a Level Playing Field Feasible? 
 The market penetration of any public plan would depend on numerous factors concerning 
eligibility, pricing, and provider participation rules.  A Lewin Group study prepared by Shiels and Haught 
(2009) estimated that an aggressive public plan reimbursing at Medicare rates would capture a large share 
of the overall market if open to employer plans.  The CBO projects that the public plans proposed by the 
House and Senate would attract fewer than 5 billion people by 2019, and that a public plan could have 
higher average premium rates as it could attract a less healthy population.  It is not clear whether a 
tendency for a public plan to attract less healthy people would eventually be accompanied by increased 
risk adjustment to shift more costs to private plans. 
 Nichols and Bertko (2009) set forth criteria, shown in Table 4, for a public plan to compete 
equally with private plans.  If legislation creating a proposed public plan reflected those criteria, it still 
could be difficult to ensure their implementation.  For example, legislative language that public plan 
premiums include a contingency margin might not ensure self-sustaining premium rates in an 
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environment of substantial pressure to make coverage affordable.  Table 4 shows two additional criteria  
for equal competition related to health insurers’ capital and taxation.   
Profits are needed to earn normal returns on capital that private insurers invest to back the sale of 
coverage and make promises to pay claims secure.  The three largest publicly-traded health insurers, 
UnitedHealth, Wellpoint, and Aetna reported GAAP premium-to-capital ratios of 3.5, 2.9, and 3.3, 
respectively, at year-end 2008.  The aggregate premium-to-capital ratio for the 13 largest publicly-traded 
health insurers combined was 3.7 (A.M. Best, 2009b).  The aggregate statutory accounting premium-to-
capital (surplus) ratio for non-profit Blue Cross Blue Shield plans was 3.1 (A.M. Best, 2009a).  These 
ratios and underlying amounts of capital are associated with an “A” financial strength rating for the 
typical health insurer.  Holding such capital may require a pre-tax margin in premiums of 2-3 percentage 
points (American Academy of Actuaries, 2009).  If a public plan were required to hold a capital cushion 
as, for example, proposed in the Senate bill, and/or to maintain some form of premium stabilization 
reserve, it would not hold the amount of capital that a private insurer would need to achieve an A rating.  
It would hold less capital and ultimately be backed by taxpayers.30   
A public insurer also would not face the same premium and income taxes that private insurers 
face (including taxes on investment returns from holding capital, which increase the cost of holding 
capital noted above).  Given that state premium taxes average about two percent of premiums, the total 
tax differential between a public and private plans could approximate 3-4 percent of premiums.  As a 
result, a public plan could have a direct cost advantage related to capital and taxation of 5 percent or more 
of premiums.   
Non-Profit Cooperatives 
 The CBO projects that government authorized, non-profit co-ops would have little market 
penetration.31  The need for or role for co-ops is not transparent, given that non-profit insurance 
companies already offer health insurance in many states and are dominant players in some states.  Non-
profit insurers would be expected to expand and enter additional states if many new buyers who seek 
health insurance as a result of premium subsidies and/or the legal mandate to buy coverage prefer dealing 
with non-profit insurers.  Co-ops would not have any inherent advantage over private health insurers in 
establishing provider networks, negotiating with providers, and monitoring healthcare utilization and 
fraud.    
 The creation of government-authorized co-ops would create some risk of on-going subsidies by 
taxpayers (if not by private health insurance buyers), of crowd-out of other plans, and of eventual 
conversion to a government-run plan if created as an alternative to a public plan (Miller, 2009a).  Like a 
proposed public plan, government-authorized co-ops would likely be backed implicitly if not explicitly by 
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taxpayers.  They would probably not have to hold the amounts of capital that private health insurers hold, 
and they would not have to pay income or premium taxes that private for-profit and non-profit insurers 
must pay.  There could be pressure for government-authorized co-ops to offer artificially low premium 
rates, with an attendant risk that they would experience persistent operating losses and require additional 
subsidies.  Although co-ops would initially be required to negotiate their own reimbursement rates with 
providers, substantial pressure could arise over time for centralized negotiations.  As would be true for a 
public plan, any ability of co-ops to undercut reimbursement would shift more costs to other payers, 
increasing crowd out of other health plans.   
POLICY RESCISSIONS AND THE ANTITRUST EXEMPTION 
 The House and Senate bills would override many states’ laws regarding health insurance policy 
rescissions.  The house bill would repeal the limited antitrust exemption for health insurance and medical 
liability insurance.  An amendment to that effect will likely be proposed in the Senate. 
Policy Rescission 
 Traditional practice, governed by common law, statute, and regulation, is for insurers to rely in 
underwriting and pricing on accurate disclosure by applicants without conducting a detailed investigation 
of medical history.  Companies practice ex post auditing—conducting more detailed and costly reviews of 
a subset of applications following policy issue—sometimes when expensive treatment is sought soon after 
issue.  This system lowers underwriting costs and premiums compared to more intensive upfront 
verification or to paying all claims regardless of the accuracy of disclosure.  State laws permit rescission 
only on the basis of material information, i.e., information that would have changed the insurer’s decision 
to offer coverage or the premium charged.  Some states restrict insurers’ rescission rights to instances 
where misrepresentation or concealment is directly related to the illness that produced the claim.   
During the past few years health insurers’ rescission practices have generated controversy, 
litigation, and new regulation in some states, and they have played a role in the health care reform debate.  
The House and Senate bills would prohibit rescission unless fraud (intent) could be established.  The 
Subcommittee of Oversight and Investigation of the House Committee on Energy and Commerce held 
hearings on rescission practices during June and July, 2009.    Congressional staffers' analysis of 116,000 
pages of documents from three large health insurers identified a total of about 20,000 rescissions from 
several million policies issued by the insurers over a five-year period (Committee on Energy and 
Commerce, 2009).  Company representatives testified that less than one half of one percent of policies 
were rescinded (less than 0.1% for one of the companies).32  
Congressional staffers highlighted 13 case studies of alleged abuse.  Coverage was reinstated by 
the insurer in at least five of the cases.   Five of the cases involved a rescission based on misrepresentation 
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or concealment of a condition unrelated to medical claims for which reimbursement was sought.  Two 
cases involved rescission of family coverage based on misrepresentation by the applicant; two involved 
agent misrepresentation.33  The practical effect of the House and Senate bills’ requirement proof of intent 
might be minimal given that the bills would guarantee issue of coverage without preexisting condition 
exclusions at rates that do not reflect health status.  Otherwise, requiring proof of intent for insurers to 
rescind policies would be expected to increase underwriting costs, claim costs, and premiums, and it 
might increase denial rates.   
Repeal of Antitrust Exemption 
 During October 2009 hearings by the Senate Judiciary Committee on possible repeal of the limited 
antitrust exemption for health and medical liability insurance, Senate Majority leader Harry Reid testified 
that (Reid, 2009) “exempting health insurance companies has had a negative effect on the American 
people” and that “there is no reason why insurance companies should be allowed to form monopolies and 
dictate health choices.”   
 The 1945 McCarran-Ferguson Act, which also codified state insurance regulation as national 
policy, exempts the “business of insurance” from federal antitrust law provided that the activities are (1) 
regulated by the states and (2) do not involve boycott, coercion, or intimidation.34  Until this year’s health 
care debate, the long debate over the exemption’s efficacy focused almost entirely on property/casualty 
insurance, including medical malpractice liability coverage, and specifically on the role of 
property/casualty insurance rating organizations, such as the Insurance Services Office and the National 
Council on Compensation Insurance.  These organizations collect and analyze data on property/casualty 
insurers’ loss costs, forecast loss development, and disseminate projections of future loss costs for 
hundreds of rate classes in different states.  Depending on specific state law, property/casualty insurers 
can incorporate the forecasts in their ratemaking.  In principle, this system helps produce more accurate 
property/casualty rates, thus improving financial stability, and it reduces entry barriers that otherwise 
would confront small insurers or insurers entering new markets.35  Cooperative production and 
distribution of loss development and future loss cost projections, as opposed to simply sharing historical 
data, would be unlikely to withstand antitrust scrutiny.  
 Despite allegations of large health insurers engaging in abusive monopolistic practices while 
enjoying protection from antitrust laws, there is no evidence that the antitrust exemption has contributed 
to higher health insurance costs, premiums, or profits, or, as implied by Senator Reid, of “health insurance 
monopolies . . . making health care decisions for patients.”  In contrast to many property/casualty 
insurers, health insurers do not cooperate in estimation of medical claim loss development or projection of 
future claim costs.  There is no evidence that the exemption has contributed to higher market 
21 
 
concentration.  It does not prevent review and challenge of mergers of health insurers by the Department 
of Justice.  Mergers and acquisitions of health insurers are also subject to approval by state regulators.36  
Repealing the antitrust exemption would not significantly increase competition, and it would not make 
health insurance coverage less expensive or more available.  Repealing the exemption for medical 
liability insurance would not lower its cost or prevent future malpractice insurance crises, such as those 
that occurred in the mid 1970s, mid 1980s, and earlier this decade.  The unintended consequences could 
include increased costs, reduced rate accuracy, and less competition in already fragile malpractice 
insurance markets. 
CONCLUSIONS 
  The broad reforms in the House and Senate bills would transform U.S. health insurance.  
Significant expansion in health insurance coverage would be achieved through an individual mandate and 
by expanded eligibility for Medicare, by substantial explicit and implicit premium subsidies, and by 
federal government prescription of individual and small group health insurance benefits, coverage, 
underwriting, and rating.  These changes would improve access to and affordability of health insurance 
and health care for millions of residents, with significant costs to taxpayers and other insurance buyers, 
and uncertain long-run effects on the supply of medical care.     
 Enactment of proposed reforms would demonstrate that U.S. elections can have fundamental, long-
run consequences.  The House and Senate bills represent a clear contrast to market-oriented proposals for 
expanding coverage and helping to control costs, such as those included in Senator McCain’s presidential 
campaign platform, through targeted insurance market reforms in conjunction with increased incentives 
for consumers to play a greater role in decisions regarding health and health insurance.  Those alternatives 
include:  (1) using tax credits for health insurance to help low-income persons afford coverage, to 
equalize the tax treatment of employer-sponsored and individual coverage, and to reduce the tax subsidy 
for high cost employer-sponsored plans; (2) expanding Health Savings Accounts, thus encouraging more 
consumers to assume greater financial responsibility for decisions regarding their health and medical care; 
(3) permitting people to buy insurance across state lines by authorizing health insurers that designate a 
“primary” state for regulatory oversight of underwriting, pricing, and coverage terms to sell insurance 
nationwide according to the rules of the primary state;37 (4) providing subsidies to state-based high-risk 
pools offering coverage, without regard to preexisting conditions, at subsidized premium rates that are 
high enough to discourage people from waiting to buy coverage until they need expensive care; and (5) 
providing additional, narrowly targeted subsidies to improve access to care for persons with very low 
incomes who do not currently qualify for Medicaid. 
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The longer-run effects of the broad changes proposed in the House and Senate bills on health 
insurance and health care will depend to a large extent on whether employer-sponsored coverage remains 
dominant, at least for large employee groups, with plan design and benefit determination governed largely 
by competition and private contracting.  Under one scenario, a significant majority of the non-elderly 
population will continue for many years to receive coverage on that basis.  An alternative scenario might 
see cost control pressures lead to the extension of government authority over plan design, financing, and 
reimbursable expenses throughout the market, and/or a steady reduction in employer-sponsored coverage 
and concomitant increase in coverage obtained through heavily regulated exchanges and/or a public plan. 
Regardless of whether reforms based on the House and Senate bills are enacted, the cost of 
medical care and insurance will remain on the national policy agenda for the foreseeable future.  
Projected reductions in Medicare spending under the House and Senate bills would largely help pay for 
expanded coverage for the uninsured.  Health care spending will very likely be back on the Congressional 
agenda within a few years, especially if the costs of expanded coverage exceed projections.  In particular, 
and despite projected spending reductions in the House and Senate bills, there is a good chance that the 
implicit Medicare debt will have to be renegotiated through additional spending cuts, tax increases, 
enrollee premium increases, and/or fundamental redesign of the program.  
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FIGURE 1 
U.S. Health Expenditures:  Percent of GDP and Per Capita Growth, 1961‐2007 
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FIGURE 2 
Per Capita Health Expenditures in OECD Countries in 2007 (U.S. dollar purchasing power parity) 
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FIGURE 3 
Compound Annual Growth Rate in Per Capital Health Expenditures in OECD Countries:  1997‐2007 
 
 
 
  
0%
2%
4%
6%
8%
10%
12%
$0 $500 $1,000 $1,500 $2,000 $2,500 $3,000 $3,500 $4,000 $4,500
Per capita expenditure in 1997 (U.S.$ PPP)
U.S.
29 
 
FIGURE 4 
Distribution of National Health Expenditures in OECD Countries in 2006 
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FIGURE 5 
Individual Insurance Market Average Premiums and Denial Rates, 2009 
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FIGURE 6 
Race, Ethnicity, Poverty, and Non‐Elderly Adult Uninsured Rates by Quartiles of States Ranked by 
Percent of Uninsured in 2007‐2008 (excludes Alaska, Hawaii, and D.C.) 
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Figure 7 
House and Senate Bill Maximum Premiums for Family of Four and Actuarial Values of Coverage 
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Table 1 
Relationship between Private Insurance Coverage, Income, 
Public Coverage, Race, and Ethnicity by State 
 
 Proportion 
employer 
coverage 
Proportion 
uninsured 
Constant 0.477*** 0.390*** 
(12.08) (9.769) 
Median household income 0.464*** -0.403*** 
(8.54) (-7.04) 
Proportion public coverage -0.325** -0.411*** 
(-2.63) (-3.17) 
Proportion black  -0.051 0.135*** 
(-1.21) (3.59) 
Proportion Hispanic -0.321*** 0.337*** 
(-12.69) (15.50) 
R-squared 0.796 0.781 
Insurance coverage rates for 2007-2008.  Sample excludes Alaska, Hawaii, and D.C. 
Least squares estimates;  t-ratios using robust standard errors in parentheses.   
  ***Significant at 0.01 level. 
  **Significant at 0.05 level.  
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TABLE 2 
House bill (Affordable Health Care for America Act) & the Senate bill (Patient Protection and Affordable Care Act) 
  House  Senate 
Individual mandate  Beginning in 2013; non‐compliance penalty 2.5% of 
income above filing level up to cost of basic coverage 
Beginning in 2014 if cost no more than 8% of income; 
non‐compliance penalty of $100 in 2014 increasing 
to $750 in 2019  
Employer mandate  Yes, if annual payroll at least $500,000; non‐
compliance penalty up to 8% of payroll; small 
employer tax credits  
No; fines up to $750 per worker for companies with 
50 or more full‐time employees if workers obtain 
subsidized coverage; small employer tax credits 
Medicaid expansion  Qualify with income up to 150% of FPL  Qualify with income up to 133% of FPL 
Premium subsidies  Income up to 400% of FPL  Income up to 400% of FPL 
Qualifying coverage  Broad categories of services; three cost‐sharing tiers    Broad categories of services; four cost‐sharing tiers 
Grandfathering of 
existing plans 
New plans must meet qualifying coverage 
standards; all employer plans in 2018 
New plans must meet qualifying coverage standards 
Insurance market  
reforms 
Health insurance exchange(s); guaranteed issues 
w/o pre‐existing condition exclusions or rates based 
on health status; 2‐to‐1 age rating band; risk 
adjustment  
Health insurance exchanges; guaranteed issues w/o 
pre‐existing condition exclusions or rates based on 
health status; 4‐to‐1 age rating band; risk adjustment 
Public plan  Yes; also authorizes co‐ops  Yes; states may opt out; also authorizes co‐ops 
Antitrust  Repeals exemption  Amendment to repeal exemption likely 
Projected coverage   96% of non‐elderly legal residents   94% of non‐elderly legal residents  
Projected 10‐yr cost of 
expanded coverage 
$1052 billion ($610 billion exchange subsidies; 
$425 Medicaid/CHIP; $25 billion small employer tax 
credits) 
$848 billion ($349 billion exchange subsidies; $374 
Medicaid/CHIP; $23 billion small employer tax 
credits) 
Projected taxes & fees  $781 billion, including $460 billion surcharge on 
high income taxpayers ($500,000 single, $1 mill. 
joint) and $168 billion in penalties ($33 billion 
individual;$135 billion employer); $20 billion tax on 
medical device co.  
$486 billion, including $54 billion additional 
Medicare Part A tax; $149 billion from 40% taxes 
plan costs above $8,500 ($23,000 family; 2013, CPI + 
1% indexing); $36 billion in penalties ($28 bill. 
individual; $8 bill. employer); $22 bill. tax on branded 
drug co., $19 bill. tax on device co; $60 bill. tax on 
health insurers.  
Projected spending 
reductions 
$396 billion, primarily from Medicare, including 
$170 from Medicare Advantage 
$436 billion, primarily from Medicare, including $118 
billion from Medicare Advantage 
Projected deficit impact  ‐$138 billion  ‐$130 billion 
Sources:  House and Senate bills, Congressional Budget Office (Nov. 6, Nov. 18, Nov. 20, 2009), Joint Committee on Taxation (Nov. 6 and Nov. 18, 2009).  
Miscellaneous revenues and costs not shown. 
35 
 
 
TABLE 3 
Private Health Insurers Medical Loss Ratios, Administrative Expense Ratios, and Net Income Margins 
Sample Profit or expense measure Value Source 
All private health insurance, 1965-2008a Average premium margin for profit and admin. 
expenses 
12.2% National Health 
Expenditure Data 
All private health plans, 2006 Admin. expense ratio 12% CBO (2008) 
All risk-based (non self-funded) private 
health insurance (SAP), 2006-2008 
Average medical loss ratio 
Average admin. expense ratio 
Average net income margin 
87% 
11% 
2% 
Donahue (2009) 
Publicly-traded health insurers (GAAP) Average net income, percent of  revenues, 1990-2008 3.3% Compustatb  
 Industry net income margin, 2007 
     Industry rank, 2007 
Industry net income margin, 2008 
     Industry rank, 2008 
6.2% 
28 
2.2% 
35 
Fortune industry rankings 
(annual) 
 
 
 Net income / revenues, 2007 
Medical loss ratio, 2007 
Admin. expense ratio, 2007 
Net income / revenues, 2008 
Medical loss ratio, 2008 
Admin. expense ratio, 2008 
5.3% 
81.6% 
16.8% 
3.1% 
82.9% 
18.0% 
A.M. Best (2009a) 
Non-profit Blues (SAP) Net income / revenues, 2007 
Medical loss ratio, 2007 
Admin. expense ratio, 2007 
Net income / revenues, 2008 
Medical loss ratio, 2008 
Admin. expense ratio, 2008 
1.0% 
87.3% 
12.2% 
1.4% 
86.5% 
11.9% 
A.M. Best (2009b) 
Blue Cross Blue Shield and other plans, 26 
million lives, 2007 
Commercial insured admin. expense ratio 
Commercial ASO admin. expense ratioa 
Small group admin. expense ratio 
Individual market admin. expense ratio 
11% 
7% 
11.1% 
16.4% 
Sherlock (2008) 
Private health insurers, 2002-2007 Admin. expense ratio, Mass. insurers 
Admin. expense ratio, other Northeast insurers 
Admin. expense ratio, nationwide 
10.9% 
11.1% 
11.6% 
Oliver Wyman (200x) 
aIncludes estimated premium equivalents for self-funded plans  bAuthor's calculations.
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TABLE 4 
Criteria for Level Competition between a Public Plan and Private Insurers 
Nichols and Bertko 
(2009) 
 Public plan administrators must be accountable to an entity other than the one 
regulating the marketplace. 
 Rules and regulations must be the same as for private plans.  
 The public plan cannot be Medicare. 
 Provider participation must be optional.  The public plan must not be able to 
leverage Medicare or other public program to force providers to participate. 
 The public plan should not use Medicare rates.  It should allow providers the 
freedom to negotiate as with private insurers. 
 Premium subsidies should not be dependent on choice of the public plan. 
 The public plan must be actuarially sound. 
 Public and private insurers should adhere to the same rules regarding reserves. 
 Because a government plan cannot be insolvent, it should be required to 
establish a premium stabilization fund. 
 Public and private plans should be treated the same as private plans in terms 
of special assessments or levies. 
Other   The public plans should be taxed the same way as private insurers, including 
payment of state premium taxes.  Alternatively, private insurers should be 
exempt from taxes. 
 The public plan should be required to hold enough capital, eventually 
maintained by premiums, that would allow it to receive an A or better 
financial rating if it were not backed by the government. 
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Endnotes 
 
1The California Legislature rejected an individual mandate in 2008.  Maine and Vermont programs offering 
subsidized health insurance without a mandate have attracted relatively few applicants.  The Connecticut General 
Assembly overrode a veto by the state’s governor to enact legislation in 2009 appointing a board to develop a public 
health insurance option to promote universal coverage, including low-income subsidies, to take effect by July, 2012.  
The board is authorized “to evaluate implementation of an individual mandate.”  As part of its reforms, 
Massachusetts fines employers who fail to make reasonable contributions to employee health coverage.  Hawaii has 
required employers to offer coverage to employees working at least 20 hours weekly since 1974.  Subsequent 
employer mandates in Massachusetts, Oregon, Washington, and California were either repealed or never took effect.    
2 Six states require guaranteed issue in the individual market (Kaiser Family Foundation, 2009).  Ten states have a 
rate band system limiting permissible variation of rates based on health status.  Five states allow have adjusted 
(modified) community rating laws that permit rates to vary in relation to factors such as age, location, and coverage, 
but not health status.  New Jersey and New York have pure community rating, which requires an insurer to accept 
all applicants for a given type of coverage and location at the same rate.  The small group health insurance market 
has more restrictions.  In conjunction with federal law, all states require guaranteed issue.  Thirty-five states have 
rating bands, eleven states have adjusted community rating, and New York has pure community rating.  Three states 
and the District of Columbia have no rating restrictions.  As an alternative to strict underwriting and rating 
restrictions, 34 states have a high-risk pool with guaranteed issue of basic coverage at subsidized (but still relatively 
high) rates, regardless of preexisting conditions.    
3The Pharmaceutical Research and Manufacturers of America, the American Medical Association, AARP, and many 
unions support Democrats’ proposals.  America’s Health insurance Plans (AHIP) endorsed the insurance market 
reforms, apart from a public option and narrow limits on age-related premium variation, provided that proposed 
legislation included an individual mandate with strong penalties for non-compliance.  The National Association of 
Insurance Commissioners (NAIC) endorsed the insurance market reforms provided that state regulators administer 
the regulations.  The U.S. Chamber of Commerce opposes both the House and Senate bills.   
4 Ending the comparison period in 2006 versus 2007 allowed several additional countries to be included. 
5 McKinsey (2008) provides detailed background on U.S. costs and international comparisons.  
6 See, for example, Weisbrod (1991), Newhouse (1992), Peden and Freeland (1995), Smith, Newhouse, and 
Freeland (2009), and, for evidence concerning Medicare, Finkelstein (2007). 
7 Bundorf and Pauly (2006) analyze uninsured rates, income, and the concept of “affordability” of health insurance.  
Also see Polsky and Grande (2009). 
8 See Kaiser Family Foundation (2009) for comprehensive estimates of the uninsured and their characteristics.  Also 
see O’Neill and O’Neill (2009).  Estimates of the uninsured differ depending on the data used.  National Health 
Interview Survey data suggest a somewhat smaller uninsured population (Cohen, et al., 2009). 
9 Bernard, Banthin, and Encinosa (2007) review evidence on the relationship between health insurance coverage and 
income and provide evidence that the probability of being uninsured is higher for low asset households controlling 
for income.  Sinn (1982) provides an early theoretical treatment of the effect of wealth on health insurance demand. 
10 Another source reports an estimate of 6 million in 2006 (NIHCM, 2008). 
11 Median household income had a higher partial correlation with the uninsured rate than the proportion of 
population with income below FPL.  The latter variable was not significant when added to the regressions shown, 
and the condition index for the augmented design matrix was about 60.  Qualitatively similar results to those shown 
in Table were obtained using a logit transformation of the uninsured rate. 
12 Using MEPS data, Hadley, et al. (2008) estimate that hospitals provided $35 billion and physicians provided $7.8 
billion in uncompensated care in 2008.  Also see Gruber and Rodriguez (2007), who estimate using survey data that 
uncompensated care provided by physicians was less than one percent of their revenues.  In contrast to popular 
belief, evidence suggests that the uninsured are not a primary source of emergency room use and overcrowding 
(Newton, et al., 2008; also see Anderson, Dobkin, and Gross, 2009). 
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13 See, for example, Institute of Medicine (2009).  The extent to which being uninsured increases mortality rates has 
been debated.  Compare, for example, O’Neill and O’Neill (2009) with Wilper, et al. (2009).  
14The problem is succinctly summarized by the lead line on the CBO’s health website:  “The federal budget is on an 
unsustainable path, primarily because of the rising cost of health care.”  
http://www.cbo.gov/publications/collections/health.cfmm (accessed November 18, 2009).  
15 In comparison, the U.S. public debt outstanding in July 2009 was $7.2 trillion, about half as large as 2008 GDP, or 
$47,000 per adult aged 16-64. 
16 Using the Trustees’ projections for the number of workers paying social security taxes over the next 75 years, 
$26.9 trillion translates into $4,700 per worker per year (in current dollars).  Based on the Trustees’ assumptions, a 
worker entering the labor force and expecting to work 40 years would need about $114,000 today to fund an annual 
obligation of that magnitude. 
17 Neither bill authorizes subsidized coverage for unauthorized (illegal) immigrants.  The extent to which either bill 
contains a sufficient enforcement mechanism to preclude such coverage is disputed. 
18 The House bill would permit states to combine to offer coverage through a regional exchange.  Under both bills 
subsides would only be available through the exchange (or exchanges). 
19 The Senate bill’s risk adjustment provisions are more elaborate, including a reinsurance plan to for high cost 
enrollees.  Swartz (2003) argues that government reinsurance of high cost cases would be an efficient means of 
deterring incentives for insurer risk selection. 
20 Pauly (1970) provides an early treatment of community rating. 
21 There also has been debate, including queries of President Obama by the press, about whether a mandate 
constitutes a tax even if premium rates were to equal expected costs because it forces some people purchase 
coverage for which the perceived benefit is less than the premium, and concerning whether a mandate to purchase a 
specific service is constitutional. 
22 In his September 22nd letter to Senate Finance Chairman Max Baucus on the Senate Finance Committee proposal, 
CBO Director Douglas Elmendorf acknowledged that, other factors held equal, “premiums in the new insurance 
exchanges would tend to be higher than the average premiums in the current-law individual market . . . because the 
new policies would have to cover preexisting medical conditions and could not deny coverage to people with high 
expected costs of health care.”  He then noted that the “CBO has not analyzed the magnitude of that effect.”  
Evidence of adverse selection in states with community rating and other significant rating restrictions has been 
mixed (Buchmueller and DiNardo, 2002; Monheit and Cantor, 2004; Pauly and Herring, 2006; Wachenheim and 
Leida, 2007; Parente and Bragdon, 2009; also see Pauly and Herring, 2007; Kowalski, Congdon, and Showalter, 
2008; LoSasso, 2008).  Parente, et al. (2008) reviews prior studies on effects of state regulations on health insurance 
premiums.   
23 Studies provide mixed evidence of the extent that state mandated health insurance benefits have significantly 
increased premiums (e.g., Monheit, 2007;  LaPierre, et al., 2009). 
24 Massachusetts had inherent advantages on this dimension.  The estimated proportion of its non-elderly population 
without health insurance before the mandate (9 percent) was half the national rate, reducing the scope of subsidies 
needed to approach universal coverage compared with many other states.  Massachusetts was also able to reduce the 
need for new taxes, at least initially, with substantial federal funding from a special Medicaid waiver and by 
accessing substantial sums from its previously established fund for uncompensated hospital care.   As noted above, 
the costs of Medicaid expansion and premium subsidies in Massachusetts have exceeded projections.   
25 A non-profit insurer has the largest market share in some states.  In his health care speech before a joint session of 
Congress on September 9, 2009, the President pointed to Alabama as an example of high market concentration.  The 
state's largest health insurer, the nonprofit Blue Cross and Blue Shield of Alabama, has about a 75% market share 
(Gray, 2009). A representative of the company indicated that its "profit" averaged only 0.6% of premiums the past 
decade, and that its administrative expense ratio is 7% of premiums, the fourth lowest among 39 Blue Cross and 
Blue Shield plans nationwide.  A December 31, 2007 report by the Alabama Department of Insurance indicates that 
the insurer's ratio of medical-claim costs to premiums for the year was 92%, with an administrative expense ratio 
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(including claims settlement expenses) of 7.5%.  Its net income, including investment income, was equivalent to 2 
percent of premiums in that year.   A Consumer Reports survey reported that Blue Cross and Blue Shield of 
Alabama ranked second nationally in customer satisfaction among 41 preferred provider organization health plans. 
These data suggest that efficiency could help explain the company’s large market share, as opposed to a lack of 
competition—especially since there are no obvious barriers to entry or expansion in Alabama faced by large national 
health insurers. 
26 Another issue has been the costs to providers of interacting with private insurers (see, e.g., Casalino, et al., 2009, 
providing survey evidence of physician time spent interacting with private insurance plans).   
27 The higher administrative expense ratios shown for publicly-traded insurers based on generally accepted 
accounting principles (GAAP) in part reflect that the ratios include expenses for administrative expenses for self-
funded ASP arrangements in the numerator and ASO fees in the denominator, whereas statutory accounting 
principles (SAP) offsets ASO fees against expenses.   
28 Sherlock notes that assertions that administrative expenses in the individual and small group markets are often 30 
percent are higher are based on estimates by Hay Huggins for the Congressional Research Service (1988), which in 
significant part were based on underwriters’ projections, and that such assertions often are based on ratios of 
expenses to medical claim costs rather than premiums. 
29 The American Hospital Association, for example, reported an aggregate operating margin for U.S. community 
hospitals of approximately four percent in 2007, and about one-fourth of hospitals had negative operating margins 
(American Hospital Association, 2009, charts 4.1 and 4.2). 
30 In principle, an iron-clad premium stabilization fund might fully substitute for capital.  That result seems unlikely 
in practice, especially in view of the history of other federal insurance programs. 
31 Haislmaier (2009) elaborates the basic features of co-ops and how they might be designed.  Also see Miller 
(2009a). 
32 The rate would be higher among new customers and for new customers that submit large claims (see, e.g., 
Haycock, Ledford, and Harbage, 2009).  
33 The other case studies involved a physician misdiagnosis, a diagnosis not disclosed to the patient, and an applicant 
who had been treated for Barrett’s Esophagus who did not disclose “stomach or ulcer symptoms.” 
34 Its passage followed a 1944 Supreme Court ruling that insurance was interstate commerce and therefore subject to 
federal antitrust law, which cast doubt on states’ exclusive regulatory role and the legality of then typical agreements 
among property/casualty insurers to use rates developed by insurance rating bureaus.  Most states responded to the 
McCarran-Ferguson Act by enacting or modifying laws requiring prior regulatory approval of property/casualty 
insurance rates, thus qualifying collective ratemaking for the exemption.  The next several decades saw a steady 
erosion of the role of collective pricing systems in conjunction with increased price competition, less price 
regulation, and a significant narrowing of the antitrust exemption’s scope by the courts. 
35 Small property/casualty insurers are particularly strong supporters of the exemption. 
36 The Department of Justice challenged the 2005 merger of UnitedHealth Group and PacifiCare, and obtained a 
consent decree requiring the divestiture of certain portions of the latter organization’s commercial health business 
for the merger to close. Earlier in 2009, the Pennsylvania Insurance Commissioner Joel Ario entered a ruling that 
derailed a proposed merger between the state’s two largest health insurers, Highmark and Independence Blue Cross.  
The antitrust exemption did not prevent lawsuits by the American Medical Association (AMA) and New York 
Attorney General Andrew Cuomo over allegedly flawed databases operated by Ingenix, a UnitedHealth subsidiary, 
and used by several major health insurers.  The suits alleged that use of the databases led to underpayments to 
physicians for out-of-network care.  UnitedHealth settled the cases and agreed to fund an independent database.  The 
AMA subsequently sued Aetna and Cigna for reimbursement of alleged underpayments.  
37 Parente, et al. (2008) provides estimates from a micro-simulation model of the effects of this type of proposal. 
